Chloride channel 7 alpha subunit
The CLCN7 gene encodes a chloride channel that is involved in regulation of bone formation. Mutations cause atosomal dominant and recessive forms of osteopetrosis.
Genetests:
Related Diseases:
References:
1. |
Yoneyama T et al. (1992) Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II--a family study.
|
2. |
Bénichou O et al. (2001) Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.
|
3. |
Cleiren E et al. (2001) Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
|
4. |
Kornak U et al. (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
|
5. |
Lam CW et al. (2007) DNA-based diagnosis of malignant osteopetrosis by whole-genome scan using a single-nucleotide polymorphism microarray: standardization of molecular investigations of genetic diseases due to consanguinity.
|
6. |
Brandt S et al. (1995) ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family.
|
7. |
Blair HC et. al. (2004) In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
|
8. |
Kasper D et al. (2005) Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.
|
9. |
Lange PF et al. (2006) ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.
|
10. |
Graves AR et al. (2008) The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes.
|
11. |
Weinert S et al. (2010) Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.
|
12. |
NCBI article
NCBI 1186
|
13. |
OMIM.ORG article
Omim 602727
|
Update: Aug. 14, 2020